ICAM1 and neoplasm: The down-regulation of ICAM-1 after TGF-β1 stimulation underlines the tumor’s evasion from the immune system by reducing immune cell infiltration into the tumor microenvironment and tumor cell elimination by the tumor infiltrating lymphocytes (TILs).